Endologix, Inc. (ELGX) Posts Q1 Loss of 7c/Share; Reaffirms Outlook

Endologix, Inc. (NASDAQ: ELGX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.5 million versus the consensus estimate of $23.29 million.

Endologix, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• Omega Flex (OFLX) Tops Q2 EPS by 27c